LONDON - Polar Capital Global Healthcare Trust PLC (LSE:PCGH) announced amendments to its final results for the fiscal year ended September 30, 2024. The company's net asset value (NAV) per ordinary share reported a total return of 14.95%, surpassing the MSCI ACWI Healthcare Index's total return of 9.88%. Since the company's restructuring on June 20, 2017, the NAV per ordinary share has seen a total return of 92.62%, outperforming the benchmark index's total return of 82.42%.
The trust's total net assets increased by 14.29% to £479,073,000, up from £419,182,000 in the previous year. The NAV per ordinary share rose to 395.05p, a 14.29% increase from last year's 345.66p. The price per ordinary share also saw a significant rise of 17.87% to 376.00p. The discount per ordinary share, which measures the difference between the share price and NAV, narrowed to 4.82% from 7.71% in the previous year.
The ongoing charges for the trust remained low, with a slight increase to 0.88% from 0.87% in 2023. The trust also reported a negative net cash/gearing of (0.91%), a substantial shift from the previous year's 9.37%, indicating a more conservative capital structure.
Dividends for the year amounted to 2.40p per ordinary share, with the first interim dividend of 1.20p paid on August 31, 2024, and the second interim dividend of 1.20p to be paid on February 28, 2025. The ex-dividend and record dates for the second interim dividend have been amended to February 6, 2025, and February 7, 2025, respectively, with the declaration made today.
Polar Capital Global Healthcare Trust PLC's performance highlights its ability to navigate the healthcare market, delivering strong returns to its shareholders. The trust's results are based on a press release statement, providing investors with the latest financial outcomes and strategic updates.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.